Mestre-Bach, Gemma
Granero, Roser
Fernández-Aranda, Fernando
Potenza, Marc N. http://orcid.org/0000-0002-6323-1354
Jiménez-Murcia, Susana
Funding for this research was provided by:
FUNCIVA (post-doctoral training award)
ICREA Academia
Connecticut Council on Problem Gambling
Ministerio de Ciencia, Innovación y Universidades (RTI2018-101837-B-100)
Delegación del Gobierno para el Plan Nacional sobre Drogas (2019I47, 2021I031)
Article History
Accepted: 29 October 2022
First Online: 25 November 2022
Declarations
:
: Dr. Fernández-Aranda received consultancy honoraria from Novo Nordisk and editorial honoraria as EIC from Wiley. Dr. Potenza has consulted for Opiant Therapeutics, Game Day Data, Baria-Tek, the Addiction Policy Forum, AXA and Idorsia Pharmaceuticals; has been involved in a patent application with Yale University and Novartis; has received research support from Mohegan Sun Casino and the National Center for Responsible Gaming; has participated in surveys, mailings or telephone consultations related to drug addiction, impulse-control disorders or other health topics; has consulted for and/or advised gambling and legal entities on issues related to impulse-control/addictive disorders; has provided clinical care in a problem gambling services program; has performed grant reviews for research-funding agencies; has edited journals and journal sections; has given academic lectures in grand rounds, CME events and other clinical or scientific venues; and has generated books or book chapters for publishers of mental health texts. The other authors do not report disclosures.
: The study was conducted in accordance with the Declaration of Helsinki of 1975, as revised in 2000. The participants were recruited for different research projects approved by the Ethics Committee of the Bellvitge University Hospital (Refs: PR241/11, PR286/14, PR329/19, PR338/17 and PR393/17).
: All participants provided written informed consent.